Katerina-Marina Pilala

5PUBLICATIONS
11CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsInnate immunityPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 09, 2025
Loss of METTL3 m6A methyltransferase results in short-term progression and poor treatment outcome of bladder cancer patients.

Katerina-Marina Pilala, Stella Koroneou, Maria-Alexandra Papadimitriou

|Apr 05, 2024
MIR145 Core Promoter Methylation in Pretreatment Cell-Free DNA: A Liquid Biopsy Tool for Muscle-Invasive Bladder Cancer Treatment Outcome.

Katerina-Marina Pilala, Georgios Kotronopoulos, Panagiotis Levis

|Jun 10, 2023
Deregulated Expression of IL-37 in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the IL-37e Isoform.

Maria Papasavva, Styliana Amvrosiou, Katerina-Marina Pilala

|Feb 11, 2023
Evaluation of the Small Heat Shock Protein Family Members HSPB2 and HSPB3 in Bladder Cancer Prognosis and Progression.

Despoina D Gianniou, Aimilia D Sklirou, Maria-Alexandra Papadimitriou

|May 17, 2022
Epi-miRNAs: Modern mediators of methylation status in human cancers.

Maria-Alexandra Papadimitriou, Konstantina Panoutsopoulou, Katerina-Marina Pilala

Pageof 1

Frequent Collaborators

5 joint publications

Andreas Scorilas

5 joint publications

Margaritis Avgeris

3 joint publications

Maria-Alexandra Papadimitriou

2 joint publications

Konstantina Panoutsopoulou